Our physician-experts for IDWeek weigh in on the most important research to emerge from the conference.
Last week, the NEJM Group Conference Updates team covered IDWeek 2021. We wrapped up our coverage by talking to the two physicians who served as our expert guides for the conference — NEJM Journal Watch Infectious Diseases editors Carlos del Rio and Rajesh Gandhi. They talked to Joe Elia about their favorite studies presented at IDWeek 2021, offering their insights on remdesivir, monoclonal antibodies, and HIV treatment and prevention. Watch the interview to hear all their observations.